| Line Item | 2023-12-29 | Y/Y |
|---|---|---|
| Revenue | $15.44B | +7.2% |
| Cost of Revenue | $13.19B | +7.2% |
| R&D Expense | $128.0M | +10.3% |
| SG&A Expense | $942.0M | -0.8% |
| Operating Income | $621.0M | -42.9% |
| Pre-tax Income | $403.0M | -54.5% |
| Income Tax | $195.0M | +1.0% |
| Net Income | $199.0M | -70.9% |
| EPS (Basic) | $1.45 |
| Line Item | 2023-12-29 | Y/Y |
|---|---|---|
| Cash & Equivalents | $777.0M | +50.6% |
| Accounts Receivable | $2.43B | +3.4% |
| Inventory | $310.0M | +8.0% |
| Current Assets | $4.00B | +9.9% |
| Total Assets | $12.70B | -2.9% |
| Current Liabilities | $2.99B | -24.2% |
| Long-term Debt | $4.66B | +18.7% |
| Line Item | 2023-12-29 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.17B | +18.2% |
| Investing Cash Flow | -$211.0M | +32.6% |
| Financing Cash Flow | -$715.0M | +17.3% |
| -71.0% |
| EPS (Diluted) | $1.44 | -71.0% |
| Total Liabilities |
| $8.44B |
| -3.2% |
| Stockholders' Equity | $4.20B | -2.3% |